Tickers: XTSX:EYC, PINX:EYCCF
Tags: #Healthcare
Thursday, April 8, 2020 - TheNewswire - Toronto, ON, Canada - Eyecarrot Innovations Corp., (Eyecarrot) (TSXV:EYC) (OTC:EYCCF) is pleased to announce the appointment of Patrick Morris as an Independent Director of the Company.
Mr. Morris is an entrepreneur and capital market executive with over 15 years of experience, raising funds for microcap companies in a number of industries, including pharmaceutical cannabis, resource exploration, blockchain technologies and finance. In addition, Mr. Morris co-created and co-produced Canada's first nationally syndicated radio show about growth stock opportunities, which was broadcast on 14 of the top-rated news talk stations across Canada. Prior to entering the capital markets, Mr. Morris had five years of experience in wine and spirits importing, sales and portfolio management.
"I am pleased to welcome Mr. Morris to the Eyecarrot team. Mr. Morris' experience and perspective will help the company build its brand and revenue. His participation will be a beneficial outside perspective as we continue to develop our long-term strategy globally." stated Adam Cegielski, Founder | CEO
Mr. Morris, commented, "I am excited to join the Eyecarrot team. They have built an impressive portfolio of software, hardware and education content within the Binovi platform. The ability to impact human performance remotely through this technology represents an exciting and timely opportunity".
For additional information, please visit https://www.eyecarrot.com/investors
The company has now closed the ConnectMe transaction.
About Eyecarrot Innovations Corp
Eyecarrot is a human performance technology company that has developed Binovi , a hardware and software-centered platform. Binovi combines hardware, software, specialized expert knowledge, and unique big data insights in order to deliver customized one-on-one training and treatment. Binovi is designed for vision optimization and the enhancement of cognitive skills related to human performance. We are working together under a common banner to help neuro-optometry, vision rehabilitation, and vision performance professionals gain measurable results in less time, and with less effort.
On behalf of the Board of Directors
Adam Cegielski
Founder | CEO
Investor Relations
Email: invest@eyecarrot.com
Toll-free: 1 (844) 866-6162
https://www.eyecarrot.com/investors/
Forward looking information:
Certain statements contained in this news release constitute "forward-looking information" as such term is used in applicable Canadian securities laws. Forward-looking information is based on plans, expectations and estimates of management at the date the information is provided and is subject to certain factors and assumptions, including, that the Company's financial condition and development plans do not change as a result of unforeseen events and that the Company obtains regulatory approval. Forward-looking information is subject to a variety of risks and uncertainties and other factors that could cause plans, estimates and actual results to vary materially from those projected in such forward-looking information. Factors that could cause the forward-looking information in this news release to change or to be inaccurate include, but are not limited to, the risk that any of the assumptions referred to prove not to be valid or reliable, that occurrences such as those referred to above are realized and result in delays, or cessation in planned work, that the Company's financial condition and development plans change, and delays in regulatory approval, as well as the other risks and uncertainties applicable to the Company as set forth in the Company's continuous disclosure filings filed under the Company's profile at www.sedar.com . The Company undertakes no obligation to update these forward-looking statements, other than as required by applicable law. Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Copyright (c) 2020 TheNewswire - All rights reserved.
